본문 바로가기

Extensively drug-resistant tuberculosis in Myanmar: burden and mutations causing second-line drug resistance

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q3Scopus Q2
피인용
Web of Science 5Scopus 6
FWCI (Scopus)
0.47
JCR IF
JCR 2017 2.392
ISSN
1027-3719

저자

  1. Ei, P. W.제1저자Advanced Molecular Research Centre, Department of Medical Research, Yangon, Myanmar
  2. Aung, W. W.Advanced Molecular Research Centre, Department of Medical Research, Yangon, Myanmar
  3. Nyunt, W. W.National Tuberculosis Programme, Department of Public Health, Naypyidaw, Myanmar
  4. Swe, T. L.National Tuberculosis Programme, Department of Public Health, Naypyidaw, Myanmar
  5. Htwe, M. M.Advanced Molecular Research Centre, Department of Medical Research, Yangon, Myanmar
  6. Win, S. M.Advanced Molecular Research Centre, Department of Medical Research, Yangon, Myanmar
  7. Aung, S. T.National Tuberculosis Programme, Department of Public Health, Naypyidaw, Myanmar
  8. 장철훈Pusan National University Yangsan Hospital, Yangsan, South Korea
  9. Lee, H. Y.교신저자Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University, Wonju Campus, Seoul, South Korea
  10. Lee, J. S.Section of Microbiology, International Tuberculosis Research Center, Masanhappo-gu, Changwon-si, Gyeongsangnam-do, South Korea

초록

SETTING: Two tuberculosis (TB) reference laboratories in Myanmar. OBJECTIVES : To determine the proportion of extensively drug-resistant TB (XDR-TB) cases among multidrug-resistant TB (MDR-TB) cases and the mutations that cause resistance to second-line drugs in Myanmar. DESIGN: This was a cross-sectional, retrospective study. Multidrug-resistant Mycobacterium tuberculosis isolates were collected during 2015-2016. Phenotypic drug susceptibility testing (DST) was performed and drug-resistant mutations identified by sequencing. Genotypes were determined to explain relationships between drug resistance patterns and genotypes. RESULTS : Of 89 MDR-TB isolates, 12 were XDR-TB and 24 were pre-XDR-TB, with 21 resistant to fluoroquinolones (FQs) and 3 to second-line injectable agents (SLIDs). High rates of cross-resistance among second-line drugs were observed. Correlations between phenotypic and molecular DST against FQs and SLIDs were 91% in both cases. The most frequent mutation in FQ-resistant isolates was D94G (8/21) in gyrA and A1401G (11/15) in rrs in those resistant to SLIDs. The dominant genotype was the Beijing type (76/89). CONCLUSION: There were high proportions of XDR-TB and pre-XDR-TB among MDR-TB cases; cross-resistance among second-line drugs was high, with various types of genetic mutations. These data suggest that resistance to second-line anti-tuberculosis drugs should be monitored intensively, and molecular DST should be employed.

키워드

MDR-TBXDR-TBpre-XDR-TBfluoroquinoloneSLIDsMYCOBACTERIUM-TUBERCULOSISCROSS-RESISTANCECAPREOMYCINKANAMYCINSTRAINSFLUOROQUINOLONEAMIKACINASSAY

식별자

Scopus EID
2-s2.0-85039055497
WoS UID
000429780700012